Clearside Biomedical price target lowered to $4 from $6 at Needham
Needham lowered the firm’s price target on Clearside Biomedical (CLSD) to $4 from $6 but keeps a Buy rating on the shares. The company’s Q4 ...
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
This newly issued patent will strengthen Ocean Biomedical’s intellectual property portfolio and provides protection in one of the world’s largest pharmaceutical markets. The granted claims cover the ...
Columbia University’s interim president steps down and returns to her former post
Katrina Armstrong’s move comes days after Columbia agreed to a host of policy changes demanded by the Trump administration to ...
News-Medical.Net1h
Embracing AI for more efficient and effective peer review in science
It is expected that in 2025, approximately three million articles will be indexed in Scopus and the Web of Science.
Metal Organic Frameworks (Zinc, Copper, Iron, Aluminium, Chromium) Market Global Forecast to 2030
The report will help the market leaders/new entrants in this market with information on the closest approximations of the ...
AZoRobotics on MSN15h
Enhancing Efficiency and Maneuverability in Underwater Robotics
The study analyzes Miniature Underwater Robots, focusing on propulsion efficiency and AI-driven control, paving the way for ...